Skip to content

NEWHOUSE PHARMACEUTICALS

Active Risk: not assessed Private limited companyfounded 2018active for 8 yearsMeensesteenweg 82, 8870 IzegemKBO/BCE: BE 0687.802.947

Lifetime

8 annual accounts with figures on one time axis
peak of €243,266 in 2025
€243,266▲ 17.9%
peak of €481,599 in 2018
€142,769▲ 26.6%
peak of €1.3m in 2025
€1.3m▲ 8.6%
€1.4m▼ 7.0%
Board1 name since 2018
- 
Documentsfilings and deeds
25-08-202625 days late
2025abbreviated format
Gross margin from €206,397 to €243,266Result from €112,764 to €142,769Dividend €40,000Cash from €102 to €29,115

Key points

from the 2025 annual accounts

Equity

€1.3m ▲ 8.6%

NEWHOUSE PHARMACEUTICALS has made a profit in every financial year since 2018.

Turnover

≈ €380,000 estimated

The abbreviated format states no turnover.

Filings

8 annual accounts 6 late
AprilJune31 JulyOctober20202025

The 2018 accounts came in latest, 29 days after the end of the period.

Checked score

Outside the general model
Model not applicable to financial institutions
The Checked score measures liquidity, leverage and margins against the norms for trading and manufacturing companies. A bank, insurer or financial holding has a very different balance sheet. Those ratios and the score mean nothing here. So there is no financial strength either.

Bankruptcy probability within 12 months

The company is a financial institution: a bank, insurer or financial holding. Its balance sheet works differently from that of a trading or manufacturing company. A bankruptcy probability from the general model would mislead here.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

last known board
Director, until 2024
  • 88 sharesdeed of 15-01-2018
  • 87 sharesdeed of 15-01-2018

Shares in 1 company,

Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0687802947
changes role from manager to director Director discharge: · General meeting of 21-05-2024 · Gazette deed
Registered office moved within Izegem The registered office moved from Ten Bosstraat 5, 8870 Izegem to Meensesteenweg 82, 8870 Izegem · General meeting of 15-03-2018 · Gazette deed
Incorporation Founding capital of €175,000, 175 shares · Founded by and · appointed as manager · published on 15-01-2018 · Gazette deed
All 15 events

Comparable companies

same main activity, similar in size and age
Company
NEWHOUSE PHARMACEUTICALS Izegem €2.7m €243,266 48.7% -
INFINITY MANAGEMENT Izegem €3.3m €260,377 50.5% -
Taelman & Taelman Avelgem €2.4m €225,309 28.9% -
HUNAR Roeselare €2.7m €247,491 4.9% -
ELLANI Knokke-Heist €2.6m €211,312 39.2% -
LEF SOLUTIONS Moorslede €2.2m €240,212 69.1% -
Paulenco Knokke-Heist €2.8m €200,240 5.1% 2.6

These companies have the same main activity as NEWHOUSE PHARMACEUTICALS: activities of holding companies (NACE 64210). They are comparable in size and age: total assets between €2.2m and €3.3m, founded between 2016 and 2018.

Official details

Source: KBO
Status
Active since 11-01-2018Normal situation
Activity
Activities of holding companiesNACE 64210
Establishment unit
2.272.945.6698870 Izegem, since 11-01-2018
Financial year end
31 December
Peppol
Reachable since 18-11-2025
Company details

Annual accounts 2025

€2.7m=
Filing
Filed on 25-08-2026
Financials

Insights on NEWHOUSE PHARMACEUTICALS

NEWHOUSE PHARMACEUTICALS files the abbreviated format. That format states no turnover. The gross margin rose from €147,355 in 2018 to €243,266 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about NEWHOUSE PHARMACEUTICALS

What is the company number of NEWHOUSE PHARMACEUTICALS?
The company number of NEWHOUSE PHARMACEUTICALS is 0687.802.947. The VAT number is the same number with BE in front: BE 0687.802.947.
Where is NEWHOUSE PHARMACEUTICALS based?
The registered office is at Meensesteenweg 82, 8870 Izegem.Company details
What does NEWHOUSE PHARMACEUTICALS do?
According to the KBO register, the main activity is activities of holding companies (NACE 64210).
What is the legal form of NEWHOUSE PHARMACEUTICALS?
NEWHOUSE PHARMACEUTICALS is a private limited company (BV).
When was NEWHOUSE PHARMACEUTICALS founded?
NEWHOUSE PHARMACEUTICALS was founded on 11-01-2018.
Is NEWHOUSE PHARMACEUTICALS still active?
Yes, NEWHOUSE PHARMACEUTICALS is an active enterprise in the KBO register.
What is the turnover of NEWHOUSE PHARMACEUTICALS?
The turnover in financial year 2025 is ≈ €380,000. This figure is estimated from the gross margin of €243,266 and 34 comparable companies (NACE 64210). It probably lies between €320,000 and €470,000.Financials
Is NEWHOUSE PHARMACEUTICALS profitable?
In financial year 2025, NEWHOUSE PHARMACEUTICALS made a profit of €142,769.
Where can I find the annual accounts of NEWHOUSE PHARMACEUTICALS?
NEWHOUSE PHARMACEUTICALS filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of NEWHOUSE PHARMACEUTICALS due?
NEWHOUSE PHARMACEUTICALS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.